Free Trial

TerrAscend Q2 2023 Earnings Report

TerrAscend logo
$0.69 +0.13 (+24.34%)
(As of 12/17/2024 ET)

TerrAscend EPS Results

Actual EPS
-$0.05
Consensus EPS
-$0.04
Beat/Miss
Missed by -$0.01
One Year Ago EPS
N/A

TerrAscend Revenue Results

Actual Revenue
$72.12 million
Expected Revenue
$71.54 million
Beat/Miss
Beat by +$580.00 thousand
YoY Revenue Growth
N/A

TerrAscend Announcement Details

Quarter
Q2 2023
Time
N/A

Conference Call Resources

AI Crypto Tool Could Send One Coin SOARING… (Ad)

The #1 AI Coin to Buy Rapid growth predicted for little-known AI crypto project

Discover our #1 crypto pick before it's too late.

TerrAscend Earnings Headlines

TerrAscend (OTCMKTS:TSNDF) Cut to "Hold" at Atb Cap Markets
Analysts Issue Forecasts for TerrAscend FY2025 Earnings
DeFi Coin on Verge of Breakout!
The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years.
TerrAscend Reports Third Quarter 2024 Financial Results
See More TerrAscend Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like TerrAscend? Sign up for Earnings360's daily newsletter to receive timely earnings updates on TerrAscend and other key companies, straight to your email.

About TerrAscend

TerrAscend (OTCMKTS:TSNDF) cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.

View TerrAscend Profile

More Earnings Resources from MarketBeat

Upcoming Earnings